Displaying 1 - 50 of 64 results
Released Company Title Industry Topic
22 Apr 2022
17:45 CEST
VETOQUINOL Vetoquinol: Availability of the 2021 Universal Registration Document 20103015 Pharmaceuticals General meeting / Board Meeting
22 Apr 2022
17:45 CEST
VETOQUINOL Vetoquinol : Mise à disposition du Document d’enregistrement universel (DEU) 2021 20103015 Pharmaceuticals General meeting / Board Meeting
13 Apr 2022
17:45 CEST
VETOQUINOL Vetoquinol: Q1 2022 Sales: €135M 20103015 Pharmaceuticals Sales
13 Apr 2022
17:45 CEST
VETOQUINOL VETOQUINOL : CHIFFRE D’AFFAIRES 1ER TRIMESTRE 2022 : 135M€ 20103015 Pharmaceuticals Sales
24 Mar 2022
07:30 CET
VETOQUINOL VETOQUINOL : RÉSULTATS ANNUELS 2021 20103015 Pharmaceuticals Sales
24 Mar 2022
07:30 CET
VETOQUINOL Vetoquinol: 2021 Annual Results 20103015 Pharmaceuticals Sales
20 Jan 2022
19:45 CET
VETOQUINOL VETOQUINOL : CROISSANCE À DEUX CHIFFRES EN 2021 20103015 Pharmaceuticals Sales
20 Jan 2022
19:45 CET
VETOQUINOL Vetoquinol: Double-digit Growth In 2021 20103015 Pharmaceuticals Sales
15 Dec 2021
17:50 CET
VETOQUINOL Vetoquinol: 2022 Calendar of Financial Communication 20103015 Pharmaceuticals Legal
15 Dec 2021
17:50 CET
VETOQUINOL Vetoquinol : Calendrier de communication financièrepour l’année 2022 20103015 Pharmaceuticals Legal
14 Oct 2021
18:00 CEST
VETOQUINOL Vetoquinol: Third Quarter Revenues: €132 Million 20103015 Pharmaceuticals Sales
14 Oct 2021
18:00 CEST
VETOQUINOL Vetoquinol : Chiffre d’affaires du troisième trimestre : 132M€ 20103015 Pharmaceuticals Sales
29 Jul 2021
18:00 CEST
VETOQUINOL Vetoquinol: 2021 First Half Results 20103015 Pharmaceuticals Income
29 Jul 2021
18:00 CEST
VETOQUINOL VETOQUINOL : RÉSULTATS SEMESTRIELS 2021 20103015 Pharmaceuticals Income
28 Apr 2021
18:00 CEST
VETOQUINOL Vetoquinol : Mise à disposition du Document d’enregistrement universel (URD) 2020 20103015 Pharmaceuticals General meeting / Board Meeting
28 Apr 2021
18:00 CEST
VETOQUINOL Vetoquinol: Availability of the 2020 Universal Registration Document 20103015 Pharmaceuticals General meeting / Board Meeting
15 Apr 2021
17:45 CEST
VETOQUINOL VETOQUINOL :CHIFFRE D’AFFAIRES 1ER TRIMESTRE 2021 : 128M€ 20103015 Pharmaceuticals Sales
15 Apr 2021
17:45 CEST
VETOQUINOL Vetoquinol: Q1 2021 Sales: €128M 20103015 Pharmaceuticals Sales
01 Apr 2021
08:05 CEST
VETOQUINOL VETOQUINOL RÉSULTATS ANNUELS 2020 20103015 Pharmaceuticals Sales
01 Apr 2021
08:05 CEST
VETOQUINOL VETOQUINOL 2020 ANNUAL RESULTS 20103015 Pharmaceuticals Sales
08 Feb 2021
18:00 CET
VETOQUINOL Vetoquinol Acquires the Rights for Profender® from Elanco Animal Health for Canada 20103015 Pharmaceuticals Mergers, Acquiqitions, Transferts
08 Feb 2021
18:00 CET
VETOQUINOL VETOQUINOL ACQUIERT PROFENDER® D'ELANCO ANIMAL HEALTH POUR LE CANADA 20103015 Pharmaceuticals Mergers, Acquiqitions, Transferts
21 Jan 2021
18:00 CET
VETOQUINOL Vetoquinol 2020 Sales: €427.5M (up 8.0% as Reported, up 10.9% at Constant Exchange Rate) Essentials Sales: €220.6M (up 15.7% as Reported, up 17.3% at Constant Exchange Rate) 20103015 Pharmaceuticals Sales
21 Jan 2021
18:00 CET
VETOQUINOL VETOQUINOL CHIFFRE D’AFFAIRES 2020 : 427,5 M€ (+8,0% À DONNÉES PUBLIÉES ET +10,9% À CHANGES CONSTANTS), CA PRODUITS ESSENTIELS : 220,6 M€ (+15,7% À DONNÉES PUBLIÉES ET +17,3% À CHANGES CONSTANTS) 20103015 Pharmaceuticals Sales
18 Jan 2021
08:00 CET
VETOQUINOL Orion Animal Health and Vetoquinol Expand Collaboration - Vetoquinol to Distribute Orion’s Clevor® in the USA and Orion to Distribute Drontal® and Profender® Products in Finland, Hungary and Romania 20103015 Pharmaceuticals Alliances and agreements
18 Jan 2021
08:00 CET
VETOQUINOL ORION ANIMAL HEALTH ET VETOQUINOL ÉLARGISSENT LEUR COLLABORATION - VETOQUINOL DISTRIBUERA CLEVOR® D'ORION AUX ÉTATS-UNIS ET ORION DISTRIBUERA LES PRODUITS DRONTAL® ET PROFENDER® EN FINLANDE, HONGRIE ET ROUMANIE 20103015 Pharmaceuticals Alliances and agreements
11 Jan 2021
08:30 CET
VETOQUINOL VETOQUINOL ACQUIERT LES PRODUITS DRONTAL® ET PROFENDER® D'ELANCO ANIMAL HEALTH POUR L'AUSTRALIE 20103015 Pharmaceuticals News contracts
11 Jan 2021
08:30 CET
VETOQUINOL Vetoquinol Acquires the Rights for Drontal® and Profender® Families from Elanco Animal Health for Australia 20103015 Pharmaceuticals News contracts
15 Dec 2020
17:55 CET
VETOQUINOL Vetoquinol : Calendrier de communication financière pour l’année 2021 20103015 Pharmaceuticals Corporate life
15 Dec 2020
17:55 CET
VETOQUINOL Vetoquinol: 2021 Calendar of Financial Communication 20103015 Pharmaceuticals Corporate life
15 Oct 2020
19:45 CEST
VETOQUINOL Vetoquinol: Q3 2020 Sales: €114.5 Million* (up 14.3%) 20103015 Pharmaceuticals Sales
15 Oct 2020
19:45 CEST
VETOQUINOL Vetoquinol : Chiffre d’affaires 3e trimestre 2020 : 114,5 M€* (+14,3%) 20103015 Pharmaceuticals Sales
01 Sep 2020
17:45 CEST
VETOQUINOL Vetoquinol Finalizes the Acquisition of Profender® and Drontal® Product Families 20103015 Pharmaceuticals Mergers, Acquiqitions, Transferts
01 Sep 2020
17:45 CEST
VETOQUINOL Vetoquinol finalise l’acquisition des produits Profender® et Drontal® 20103015 Pharmaceuticals Mergers, Acquiqitions, Transferts
30 Jul 2020
18:00 CEST
VETOQUINOL Vetoquinol : Communiqué de mise à disposition du Rapport financier semestriel relatif à l’exercice 2020 20103015 Pharmaceuticals General meeting / Board Meeting
30 Jul 2020
17:45 CEST
VETOQUINOL Vetoquinol S.A.: 2020 First Half Results 20103015 Pharmaceuticals Income
30 Jul 2020
17:45 CEST
VETOQUINOL Vetoquinol SA : Résultats semestriels 2020 20103015 Pharmaceuticals Income
09 Jun 2020
18:34 CEST
VETOQUINOL Vetoquinol Is Moving Forward With the Acquisition of Profender® And Drontal® And Related Pipeline Assets Following Communication From the European Commission 20103015 Pharmaceuticals Mergers, Acquiqitions, Transferts
09 Jun 2020
18:34 CEST
VETOQUINOL Vetoquinol franchit une étape importante dans l'acquisition de Profender® et Drontal® ainsi que des projets de R&D suite à l’annonce de la Commission européenne 20103015 Pharmaceuticals Mergers, Acquiqitions, Transferts
27 May 2020
08:00 CEST
VETOQUINOL Vetoquinol: Combined Ordinary and Extraordinary General Meeting of May 26, 2020 20103015 Pharmaceuticals General meeting / Board Meeting
27 May 2020
08:00 CEST
VETOQUINOL Vetoquinol : Assemblée générale mixte du 26 mai 2020 20103015 Pharmaceuticals General meeting / Board Meeting
28 Apr 2020
17:45 CEST
VETOQUINOL Vetoquinol : Dominique Derveaux est nommé Directeur général délégué Pharmaceuticals Journal / appointments
28 Apr 2020
17:45 CEST
VETOQUINOL Vetoquinol: Dominique Derveaux Appointed Group Chief Operations Officer Pharmaceuticals Journal / appointments
23 Apr 2020
17:45 CEST
VETOQUINOL Vetoquinol : Mise à disposition du Document d’enregistrement universel (URD) 2019 Pharmaceuticals General meeting / Board Meeting
23 Apr 2020
17:45 CEST
VETOQUINOL Vetoquinol: Availability of the 2019 Universal Registration Document Pharmaceuticals General meeting / Board Meeting
16 Apr 2020
17:47 CEST
VETOQUINOL Vetoquinol Group: Q1 2020 Sales Pharmaceuticals Sales
16 Apr 2020
17:47 CEST
VETOQUINOL Vetoquinol : Chiffre d’affaires 1er trimestre 2020 Pharmaceuticals Sales
26 Mar 2020
08:00 CET
VETOQUINOL Vetoquinol : RÉSULTATS ANNUELS 2019 Pharmaceuticals Income
26 Mar 2020
08:00 CET
VETOQUINOL Vetoquinol: 2019 Annual Results Pharmaceuticals Income
13 Feb 2020
11:36 CET
VETOQUINOL Vetoquinol to acquire rights for Profender® and Drontal® from Elanco Animal Health for the European Economic area and the UK Pharmaceuticals Mergers, Acquiqitions, Transferts